Cardiorenal Metabolic Syndrome: LDL Cholesterol, Dyslipidemia, and Lipoprotein(a)

Join Drs Nihar Desai and Seth Martin as they discuss low-density lipoprotein (LDL) cholesterol, dyslipidemia, and lipoprotein(a) for patients with cardiorenal metabolic syndrome.
Relevant disclosures can be found with the episode show notes on Medscape www.medscape.c.... The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) pubmed.ncbi.nl...
Evolocumab and Clinical Outcomes in Patients With Cardiovascular Disease pubmed.ncbi.nl...
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients pubmed.ncbi.nl...
Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol pubmed.ncbi.nl...
Study of Heart and Renal Protection (SHARP): Randomized Trial to Assess the Effects of Lowering Low-Density Lipoprotein Cholesterol Among 9438 Patients With Chronic Kidney Disease pubmed.ncbi.nl...
Cardiovascular Risk Reduction With Icosapent Ethyl for Hypertriglyceridemia pubmed.ncbi.nl...
Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol pubmed.ncbi.nl...
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease pubmed.ncbi.nl...
Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement pubmed.ncbi.nl...
A Focused Update to the 2019 NLA Scientific Statement on Use of Lipoprotein(a) in Clinical Practice pubmed.ncbi.nl...